Develops AI-driven precision medicine platforms for hospitals and medical researchers.
Dec 2025Revenue $77.3M/yrExpenses $148M/yr
Expected break-even May 2038Cash runway ≈ 1.9 years from Dec 2025
Figures by year
When will SOPHiA GENETICS be profitable?
Its revenue and expense trends are projected to cross in May 2038. In the 12 months to Dec 2025, revenue was $77.3M and expenses $148M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $77.3M | $148M | −$70.9M |
| Dec 2024 | $65.2M | $132M | −$66.6M |
| Dec 2023 | $62.4M | $137M | −$74.8M |
| Dec 2022 | $47.6M | $135M | −$87.8M |
| Dec 2021 | $40.5M | $112M | −$71.5M |
| Dec 2020 | $28.4M | $65.8M | −$37.4M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.